Home | GSK
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Worldwide - GSK
Our contact directory for GSK operations around the world. Privacy questions: Should you have any questions or concerns regarding privacy at GSK, please reach out to us using the contact information specific to your location, provided below. Africa & Middle East. Americas.
Careers - GSK
Do your best work with us. To get ahead of disease together, continuous growth and development are vital. At GSK you'll expand your skills and build valuable connections, enabling you to do your best work.
Locations - GSK
Locations. Learn more about GSK around the world by visiting our market websites listed out below. For contact information including product information websites for healthcare professionals, visit our Worldwide directory. Our market company websites and web pages are intended for non-UK audiences.
European Commission authorises GSK’s Arexvy, the first …
Jun 7, 2023 · The European Commission has authorised Arexvy for active immunisation for the prevention of LRTD caused by RSV in adults aged 60 years and older. It is also approved in the US. The use of this vaccine should be in accordance with official recommendations.
Engaging with healthcare professionals - GSK
Healthcare professionals (HCPs) help us identify potential volunteers for clinical trials, administer the investigational medicine or vaccine to patients, and monitor the results. All HCPs who work with us on clinical trials have contracts and are paid for their work on these clinical trials.
European Commission authorises GSK’s Omjjara (momelotinib)
Jan 29, 2024 · GSK plc (LSE/NYSE: GSK) today announced the European Commission* granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor.
Internships and placements - GSK
Consider work experience at GSK. We unite science, technology and talent to get ahead of disease together. We accomplish this by bringing together outstanding people who can deliver what matters faster and better and improve the lives of billions of people around the world.
GSK unveils plan for one of Europe’s largest life science campuses …
Jul 16, 2021 · GSK has today announced that it has formally started the process of seeking a development partner to transform land within the company’s existing 92-acre Research & Development site in Stevenage into one of Europe’s largest ‘clusters’ for biotechnology and other early-stage life science companies.
Contact us - GSK
Visit our GSK Help Centre for patients, caregivers and HCPs in US. Alternatively, call us on Tel: +1 888 825 5249 Monday, Tuesday, Thursday, Friday: 08:30 AM - 5:30 PM ET